The ability of Cryptococcus neoformans to cause disease in humans varies significantly among 23 strains with highly related genotypes. In general, environmental isolates of pathogenic species 24 such as C. neoformans var. grubii have reduced virulence relative to clinical isolates, despite 25 having no differences in the expression of the canonical virulence traits (high temperature 26
growth, melanization and capsule formation). In this observation, we report that environmental 27 isolates of C. neoformans tolerate host CO 2 concentrations poorly compared to clinical isolates 28 and that CO 2 tolerance correlates well with the ability of the isolates to cause disease in 29 mammals. Initial experiments also suggest that CO 2 tolerance is particularly important for 30 dissemination of C. neoformans from the lung to the brain. Furthermore, CO 2 concentrations 31 affect the susceptibility of both clinical and environmental C. neoformans isolates to the azole 32 class of antifungal drugs, suggesting that antifungal testing in the presence of CO 2 may improve 33 the correlation between in vitro azole activity and patient outcome.
Importance 35
A number of studies comparing either patient outcomes or model system virulence across large 36 collections of Cryptococcus isolates have found significant heterogeneity in virulence even 37 among strains with highly related genotypes. Because this heterogeneity cannot be explained 38 by variations in the three well-characterized virulence traits (growth at host body temperature; 39 melanization; and polysaccharide capsule formation), it has been widely proposed that 40 additional C. neoformans virulence traits must exist. C. neoformans natural niche is in the 41 environment where the carbon dioxide concentration is very low (~0.04%); in contrast, 42 mammalian host tissue carbon dioxide concentrations are 125-fold higher (5%). We have found 43
Introduction
Cryptococcus neoformans is one of the most important human fungal pathogens and 48 causes meningoencephalitis (CME). Recent estimates indicate that 223,000 new cases of CME 49
occur each year with an annual mortality of 181,000 (1); the majority of CME disease affects 50 people infected with HIV (2). Cryptococcus species are environmental yeasts that occupy a 51 variety of niches and, therefore, Cryptococcus must transition from an environmental niche to 52 the mammalian host to cause disease (3). Most strains isolated from the environment are much 53 less virulent in animal models when compared to strains isolated from human patients. For 54 example, Litvintseva and Mitchell (4) found that only one out of ten environmental strains 55 caused mortality in a murine model of cryptococcosis by 60 days while 5/7 clinical strains 56 caused lethal infection by 40 days. In vitro, all of the strains grew at 37 o C and generated 57 comparable levels of capsule and melanin (4) . 58
Recently, Mukamera et al. systematically characterized a set of genetically similar 59 strains associated with highly variable patient outcomes (5). The virulence trends observed in 60 patients were recapitulated in the inhalational murine model, providing important validation of 61 the model as predicative of clinical virulence. Like Litvintseva and Mitchell (4), extensive 62 phenotyping of the strains did not reveal an in vitro phenotype that correlated with virulence (5). 63
These data strongly indicate that uncharacterized virulence properties beyond the "big three" of 64 host body temperature tolerance, melanization, and capsule formation plays an important role in 65 determining the virulence potential of a given cryptococcal strain (6). 66
We hypothesized that the host environment may contain additional stresses under which 67 clinical/pathogenic isolates are fitter than environmental/non-pathogenic isolates. One dramatic 68 difference between terrestrial and host environments is the concentration of carbon dioxide 69 (CO 2 ): ambient air is ~0.04% CO 2 while the CO 2 concentration in mammalian tissues is 125-fold 70 higher (5%). In ambient air, Cryptococcus, like many yeasts expresses carbonic anhydrase 71 (Can2) which catalyzes the generation of essential HCO 3 under low CO 2 concentrations. At 5% 72 CO 2 in the host, CAN2 expression is repressed presumably due to sufficient levels of HCO 3 -73 produced by dissolved CO 2 . Consequently, CAN2 is dispensable for growth at 5% CO 2 and 74 virulence in a murine host (10). Host CO 2 concentrations, however, have a profound effect on 75 C. neoformans biology because they induce capsule formation (7). Indeed, our hypothesis that 76 host concentrations of CO 2 are a significant stress to C. neoformans is supported by the fact 77 that Granger et al. noted that the growth of cultures slowed considerably after being shifted to 78 host CO 2 concentrations to induce capsule formation (8). In addition, C. neoformans strains 79 lacking calcineurin, a key stress response regulator, are hypersensitive to CO 2 (9). Finally, 80
Bahn et al. found that elevated concentrations of CO 2 inhibit C. neoformans mating (10). Taken 81 together, tolerance of host CO 2 concentrations seemed to us a potentially important 82 independent trait of C. neoformans strains that cause disease in mammals. 83
Results and Discussion 84
To test the hypothesis that CO 2 tolerance may play a role in distinguishing between 85 clinical and environmental strains of C. neoformans, we examined the CO 2 fitness of a set of 12 86 strains that had been previously characterized in the mouse pulmonary infection model by 87
Litvintseva and Mitchell (4) . The clinical and reference strain H99 as well as three other clinical 88 strains grew similarly in the presence and absence of CO 2 on RPMI media buffered to pH 7 with 89 MOPS while all but one of the environmental strains displayed a growth defect in 5% CO 2 ( Fig.  90   1A) . The serotype D reference strain JEC21 is also CO 2 sensitive relative to H99 and the 91 clinical isolates. Of 10 additional clinical strains isolated from patients at Duke University (gift of 92 John Perfect), 8 had similar growth at ambient and host CO 2 concentrations ( Fig. S1 ). Of the 12 93 strains that were examined by Litvintseva and Mitchell in animal models, only those that were 94 also the only one to cause disease. 96
To obtain a more quantitative measure of the in vitro fitness advantage of a CO 2 tolerant 97 strain over a CO 2 -sensitive strain, we carried out a competition experiment in which mCherry-98 labeled H99 strain and unlabeled, environmental strain A4-34-6 were co-cultured as a 1:1 99 mixture in ambient air or 5% CO 2 ; the ratio of H99 to A4-34-6 was determined by microscopy. 100 A4-34-6 has a 5-fold fitness defect relative to H99 in ambient air and that defect is increased to 101 50-fold in 5% CO 2 (Fig. 1B) . To determine if CO 2 tolerance is recessive or dominant, the 102 previously generated diploid AD hybrid was compared to its parental strains serotype A H99 and 103 serotype D JEC21 (11). The diploid AD hybrid is CO 2 tolerant indicating that the trait is dominant 104 (Fig. 1C ). Consistent with other yeasts (12), CO 2 is fungistatic and dose dependent (data not 105 shown). Because CO 2 /HCO 3 are substrates in reactions of central carbon metabolism (12), we 106 wondered if increasing the glucose concentration of RPMI from 0.2 to 2% would affect CO 2 107 sensitivity; however, it had no effect on the growth of the sensitive strains ( Fig. S1 ). 108
As reported by Litvintseva and Mitchell (4), all clinical strains caused lethal infections in 109 mice within 40 days while the only environmental strain to cause a lethal infection within 60 days 110 was the CO 2 tolerant strain, A1-84-14 ( Fig. 1A) . To determine if the virulence differences 111 between the CO 2 tolerant and CO 2 sensitive strains were dependent on the infection model, the 112 environmental CO 2 tolerant and CO 2 sensitive strains were compared in both the intravenous 113 model of disseminated murine cryptococcosis and in the Galleria mellonella model. Five days 114 post-infection ( Fig. 1D ), the fungal brain burden was 2 log 10 CFU/g lower in the CO 2 sensitive 115 environmental strain relative to the CO 2 tolerant environmental strain, while the CO 2 tolerant 116 environmental strain was similar to the reference strain H99. Consistent with the pulmonary 117 infection model data, the median survival of mice infected with the CO 2 tolerant environmental 118 strain is modestly longer than the highly virulent H99 reference strain ( Fig. 1E ). Mice infected with the CO 2 sensitive strain, in contrast, were asymptomatic for an additional week. The fungal 120 burden for the CO 2 sensitive strain infected mice had increased 1.7 log 10 over the 16 days ( Fig.  121 S3), indicating that environmental strain replicated very slowly in the brain. Finally, G. 122 mellonella larvae infected with CO 2 sensitive strains showed prolonged survival relative to CO 2 123 tolerant strains (Fig. 1F ). Taken together, these data strongly support a correlation between 124 CO 2 tolerance and virulence in multiple models of cryptococcal infection. 125 CO 2 levels affect the composition and function of cellular membranes in a variety of 126 biological systems which is proposed to be one possible mechanism of CO 2 -mediated, growth 127 inhibition (12, 13). The two most important anti-cryptococcal drugs, amphotericin B and 128 fluconazole, affect membrane-related processes (14) and, thus, we hypothesized that CO 2 may 129 modulate antifungal susceptibility. The minimum inhibitory concentration (MIC) was determined 130 using E-test strips on solid agar RPMI medium buffered to pH 7 with 165 mM MOPS. The MIC 131 for amphotericin B was not affected by CO 2 in any of the strains tested (≤ 2-fold change 132 between ambient air and 5% CO 2 , Fig. 2A and Fig. S4B ). In contrast, the fluconazole MIC 133 decreased approximately 8 to 10-fold (4 µg/mL to 0.5 µg/mL) for H99, CO 2 -tolerant clinical 134 isolates (C23 and C27) and environmental (A1-84-14) isolates in the presence of 5% CO 2 ( Fig.  135 2B and Fig. S4B ). The MIC of both itraconazole ( Fig. 2B ) and voriconazole (Fig. S4B) is 136 decreased at 5% CO 2 , indicating that the effect is not limited to fluconazole. 5% CO 2 has no 137 effect on the MIC of fluconazole against the C. albicans reference strain SC5314 (2 µg/mL). 138
The effect of CO 2 is also not specific to ergosterol biosynthesis inhibitors in that the sphingolipid 139 biosynthesis inhibitor myriocin is also more active at host CO 2 levels than ambient air (Fig. 2B) . 140
The physiological mechanism underlying the differential sensitivity of Cryptococcus 141 strains to host levels of CO 2 awaits further study. A variety of potential mechanisms for the 142 fungistatic and bacteriostatic effect of CO 2 have been proposed including altered membrane 143 fluidity and inhibition of biosynthetic reactions involving CO 2 (12). Despite these outstanding 144 mechanistic questions, the effects of host concentrations of CO 2 on C. neoformans virulence 145 and antifungal susceptibility have two important implications. First, CO 2 tolerance appears to be 146 an independent virulence feature of pathogenic strains of C. neoformans that correlates with 147 variations in mammalian virulence. It will be interesting to expand this analysis to determine if 148 CO 2 tolerance contributes to the variation in patient outcome (5). Based on fungal burden data 149 reported by Litvintseva and Mitchell (4), the CO 2 sensitive strains cause a significantly lower 150 lung burden than CO 2 tolerant strains while the brain burden for CO 2 sensitive strains is almost 151 undetectable at post-infection day 60. Although the CO 2 sensitive strain has reduced virulence 152 in the intravenous model, which rapidly establishes CNS infection, it is able to replicate within 153 the brain. Taken together, these preliminary and previously published data (4) indicate that CO 2 154 tolerance may play a more important role in dissemination from the lung than in replication 155 within the brain. 156
Second, the profound effect of host CO 2 concentrations on in vitro azole activity 157 identifies a potential limitation of current antifungal drug susceptibility testing conditions in 158 predicting the outcomes of patients treated with azoles. Indeed, the lack of correlation between 159
MICs generated by standardized antifungal susceptibility testing assays and clinical outcomes 160
for cryptococcal infections has been well described and a number of potential explanations for 161 this discrepancy have been proposed (15). Our data suggest that CO 2 is likely to be an 162 important factor in drug susceptibility. Although the mechanism of this effect will require 163 additional investigation, it is unlikely that high CO 2 concentrations directly reduce ergosterol 164 levels because strains with reduced ergosterol content typically have reduced susceptibility to 165 amphotericin B, a drug that binds directly to ergosterol. Regardless of the mechanism, the use 166 of host CO 2 concentrations may represent a simple adjustment that could improve the 167 correlation between MIC and clinical outcome. 168
Materials and Methods 170
Strains and growth conditions. Media was prepared using standard recipes (16). Reference 171 strains H99 and JEC21 were from stocks in the Krysan and Lin labs. Environmental and clinical 172 strains were generous gifts from Anastasia Litvintseva, Tom Mitchell and John Perfect. Strains 173 were stored in -80°C in 15% glycerol. Freshly streaked out yeast cells were grown on yeast 174 peptone 2% dextrose (YPD) medium at 30°C. For spotting assays, the cells were washed, 175 adjusted to the same cell density and serially diluted. Serial dilutions (3 µL) were then spotted 176 onto RPMI without glutamine (buffered to pH 7 with 165 mM MOPS) agar plates and incubated 177 at 37°C in ambient air or at 5% CO 2 . For the glucose supplementation assay, 2% glucose was 178 added to RPMI medium buffered to pH 7 with 165 mM MOPS. H99 was labelled with mCherry 179 by integrating plasmid pH3mCHSH2 (Addgene) into the so-called Safe-Haven 2 (SH2) locus 180 were spread onto RPMI 1640 agar medium with L-glutamine and without sodium bicarbonate. 221
The plates were allowed to dry. In disk diffusion assays, Whatman paper discs (7 mm) 222 RPMI medium buffered to pH 7 with MOPS at 37°C in ambient air (~0.04% CO 2 ) or in 5% CO 2 . 283
The information about the genotype of the strains and the median survival days of mice infected 284 by these strains intranasally were obtained from a previous study (4) neoformans var. grubii isolates from Duke University were spotted on RPMI media as described 314
in Fig. 1 . The images were taken after 3 days at 37°C in either ambient air or 5% CO 2 . The 315 images are representative of 2 biological replicates that showed identical phenotypes. All animals infected with A1-38-2 survived to day 21 and were sacrificed. The brain fungal 324 burden was determined as described in Fig. 1 . The data are plotted with those from H99 is more susceptible to fluconazole in 5% CO 2 at all concentrations tested by disk diffusion 329 assay. H99 cells were spread onto RPMI agar medium. Disks containing fluconazole (2μg,
